Therefore, it might be speculated that HER2 overexpression is important in the pathogenesis and progression of a certain subtype of BTC, leading to a dismal prognosis in this subset of patients as also observed in those patients with breast cancer with HER2 overexpression [11]. Here, ERBB2 is linked to breast carcinoma.